📅 PUBMED DAILY TRIAGE — 2026-11-09 Window: 2026-11-08T00:00:00Z → 2026-11-09T23:59:59Z (CRDT) Topics scanned: 10 | Articles reviewed: 95 | Retained: 94 High priority: 3 | Standard: 88 | Low/archive: 3 | Unsolicited finds: 6 Run status: SUCCESS
🔴🟠 HIGH PRIORITY (8+) — Best Finds by Topic
AI/ML in clinical diagnostics and imaging
· PMID-42999821 · Multimodal AI in Oral Cancer: A PRISMA-Guided Systematic Review. · 8/10 [PROMISING_PRELIMINARY] Why it matters: Results indicate that multimodal AI models consistently outperform unimodal approaches in diagnostic accuracy, AUC and
Precision oncology and genomic medicine
· PMID-42999821 · Multimodal AI in Oral Cancer: A PRISMA-Guided Systematic Review. · 8/10 [PROMISING_PRELIMINARY] Why it matters: Results indicate that multimodal AI models consistently outperform unimodal approaches in diagnostic accuracy, AUC and
Novel therapeutics: immunotherapy, CAR-T, targeted therapy
· PMID-42999638 · Efficacy and safety of stereotactic body radiotherapy combined with immune check · 8/10 [PROMISING_PRELIMINARY] Why it matters: Although the primary DCR estimate was statistically significant, its sensitivity to individual studies and the low cer
Cardiovascular-metabolic: GLP-1, SGLT2, cardiometabolic risk
· PMID-42999545 · Orforglipron improved physical and psychosocial functioning in adults with obesi · 8/10 [PROMISING_PRELIMINARY] Why it matters: Across the ATTAIN-1 and ATTAIN-2 trials, orforglipron treatment was associated with substantial body weight reduction a
· Hematologic malignancies: No high-priority finds today (best candidate: 7/10) · CBC-based diagnostics and machine learning in hematology: No high-priority finds today (best candidate: 0/10) · Early cancer detection (liquid biopsy, ctDNA, cfDNA): No high-priority finds today (best candidate: 7/10) · Aging, longevity, and population health: No high-priority finds today (best candidate: 6/10) · Rare diseases with high unmet need: No high-priority finds today (best candidate: 4/10)
🟢⚪ STANDARD (5-7) — Top by Topic
Hematologic malignancies
· PMID-42999795 · Outcomes of Patients With Chronic Lymphocytic Leukemia Treated With Bruton · 7/10 · Other · PMID-43000021 · Impact of chronic obstructive pulmonary disease on survival after chimeric · 7/10 · Treatment Innovation · PMID-42999126 · Genomic characterization of patient derived xenograft models of multiple my · 6/10 · Genomics/Precision Medicine · PMID-43000150 · [Treatment strategies for acute lymphoblastic leukemia in older adults]. · 6/10 · Other
Early cancer detection (liquid biopsy, ctDNA, cfDNA)
· PMID-42999407 · Bronchoalveolar lavage fluid cfDNA liquid biopsy-guided neoadjuvant lazerti · 7/10 · Early Detection · PMID-42999622 · Development and impact of a quality improvement intervention to increase lu · 7/10 · Early Detection · PMID-42999273 · Label-free machine learning detects a multi-cancer signal in a noninvasive · 7/10 · Other · PMID-42999361 · Tumor-Informed Circulating Tumor DNA Monitoring for Predicting Outcomes in · 7/10 · Early Detection
AI/ML in clinical diagnostics and imaging
· PMID-42999757 · Predictive Analytics and Workflow Automation to Reduce Administrative Burde · 6/10 · Diagnostics · PMID-43000110 · Artificial intelligence in glaucoma diagnosis and management: a systematic · 6/10 · Diagnostics · PMID-43000007 · Residual diagnostics and structural support in machine-learning prediction · 5/10 · Other · PMID-43000096 · Identifying Structural Heart Disease and Prioritizing Echocardiography Thro · 5/10 · Diagnostics
Precision oncology and genomic medicine
· PMID-42999607 · CEACAM5-Targeted Therapies in Solid Tumors: Biological Barriers and Next-Ge · 7/10 · Genomics/Precision Medicine · PMID-43000090 · CTTN amplification and overexpression predict poor prognosis and immunother · 7/10 · Treatment Innovation · PMID-42999371 · Single-cell profiling reveals GABBR1 as a cuproptosis-regulated prognostic · 7/10 · Genomics/Precision Medicine · PMID-42999844 · Next-Generation Cancer Nanovaccines: Reprogramming the Tumor Microenvironme · 6/10 · Prevention
Novel therapeutics: immunotherapy, CAR-T, targeted therapy
· PMID-42999803 · Outcomes of Patients with Rare Cancers Treated with Immune Checkpoint Inhib · 7/10 · Treatment Innovation · PMID-42999620 · Single-cell and spatial transcriptome analyses unveil that MYH11 links stem · 6/10 · Treatment Innovation · PMID-42999628 · Normalized administered atezolizumab dose and clinical outcomes in advanced · 6/10 · Other · PMID-42999863 · Trends and Frontiers in Stem Cell Research for Sepsis: A Bibliometric Analy · 6/10 · Other
Cardiovascular-metabolic: GLP-1, SGLT2, cardiometabolic risk
· PMID-42999643 · Impact of BMI on Ramadan fasting in individuals with type 2 diabetes mellit · 7/10 · Drug Development · PMID-42999519 · Severe obesity as an independent risk factor for post-operative dislocation · 7/10 · Other · PMID-43000186 · Weaker or Just Lighter? Monitoring Strength and Function, Not Just Lean Mas · 7/10 · Drug Development · PMID-42999919 · Cardiovascular diseases and guideline-directed medical therapy in low socio · 7/10 · Drug Development
Aging, longevity, and population health
· PMID-43000212 · Circulating Tsukushi Predicts Incident Sarcopenia and Functional Decline in · 6/10 · Genomics/Precision Medicine · PMID-43000031 · Which Urinary Incontinence Subtypes Are More Strongly Linked to Sarcopenia · 6/10 · Public Health · PMID-43000169 · Sleep characteristics and sarcopenia in patients undergoing peritoneal dial · 5/10 · Other · PMID-43000194 · Clinical Evaluation of Apple-Derived Exosome After Microneedling for Facial · 5/10 · Public Health
Rare diseases with high unmet need
· PMID-42999547 · Unifocal Frontal Bone Langerhans Cell Histiocytosis Presenting as Persisten · 4/10 · Other · PMID-43000146 · [Prednisone-responsive pure red cell aplasia associated with polymyalgia rh · 4/10 · Other
💡 UNSOLICITED FINDS
· PMID-42999878 · Osteoradionecrosis in patients with head and neck cancer after reirradiation - a · 5/10 A higher study-level proportion of patients receiving adjuvant reirradiation was associated with increased observed OR · PMID-42999387 · Phenotypic Clustering as a Tool for Uncovering Hidden Risk Profiles in End-stage · 5/10 All rights are reserved, including those for text and data mining, AI training, and similar technologies. · PMID-42999902 · Salvage High-Dose-Rate Brachytherapy for Localized Prostate Cancer Recurrence: A · 5/10 In the no-ADT subgroup (n = 83), median overall survival was 113 months, and median ADT-free survival reached 88 month · PMID-42999892 · Metastasis-directed therapy in addition to definitive locoregional radiotherapy · 5/10 In chemotherapy-responsive de novo mNPC treated with definitive LRRT, consolidative MDT was associated with improved di · PMID-42999678 · SGLT1 inhibition in cystic fibrosis: From preclinical evidence to clinical poten · 4/10 As a mutation-agnostic, multi-systemic approach, SGLT1 inhibition holds potential for addressing the extrapulmonary and
📊 TODAY'S BREAKDOWN
By research category:
- Other: 36
- Genomics/Precision Medicine: 16
- Drug Development: 10
- Diagnostics: 9
- Treatment Innovation: 8
- Early Detection: 5
- Prevention: 5
- Public Health: 5
By evidence maturity:
- Exploratory: 66
- Validated: 21
- Potentially Practice-Changing: 7
By source type:
- peer_reviewed: 89
- preprint: 5
By watchlist topic (reviewed / kept / highest score):
- Hematologic malignancies: reviewed=15, high=0, std=12, best=7/10
- CBC-based diagnostics and machine learning in hematolog: reviewed=0, high=0, std=0, best=0/10
- Early cancer detection (liquid biopsy, ctDNA, cfDNA): reviewed=12, high=0, std=9, best=7/10
- AI/ML in clinical diagnostics and imaging: reviewed=15, high=1, std=14, best=8/10
- Precision oncology and genomic medicine: reviewed=15, high=1, std=14, best=8/10
- Novel therapeutics: immunotherapy, CAR-T, targeted ther: reviewed=15, high=1, std=14, best=8/10
- Cardiovascular-metabolic: GLP-1, SGLT2, cardiometabolic: reviewed=15, high=1, std=13, best=8/10
- Aging, longevity, and population health: reviewed=9, high=0, std=9, best=6/10
- Rare diseases with high unmet need: reviewed=5, high=0, std=2, best=4/10
- Sentinel scan: reviewed=10, high=0, std=6, best=5/10
Topics with zero 8+ articles this run: Hematologic malignancies, CBC-based diagnostics and machine learning in hematology, Early cancer detection (liquid biopsy, ctDNA, cfDNA), Aging, longevity, and population health, Rare diseases with high unmet need
🔧 RUN NOTES
- Window: 1-day CRDT incremental (2026-11-08 → 2026-11-09).
- T2 (CBC/ML hematology): 0 results for this window; no fallback required (valid empty).
- 95 unique PMIDs retrieved; 1 excluded (PMID 42999894, published erratum).
- 94 articles classified; EFetch abstracts retrieved for 89/95 PMIDs (6 missing/empty despite 'Has Abstract' in ESummary — same-day CRDT propagation lag).
- PMID 42999607 (CEACAM5 review): study_design corrected from 'Clinical trial (phase)' to 'Narrative review'; score adjusted 8→7.
- No prior fingerprints loaded (state.json last_successful_run = 2026-06-27); alert deduplication not applied.
- Attempt 1 of 3; awaiting programmatic validation.